Clinical Trials Browser

Completed × Neuroblastoma × naxitamab × Clear all

NCT03033303 2025-10-07

A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma

Phase 2 Completed

Neuroblastoma

NCT02650648 2025-07-30

Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT06438614 2024-08-29

NICE

Phase 2 Completed

Neuroblastoma, Sarcoma